Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/23117
Başlık: | Capecitabine-induced cardiotoxicity mimicking myocardial infarction |
Yazarlar: | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. 0000-0002-8974-8837 Şentürk, Tunay Kanat, Özkan Evrensel, Türkkan Aydınlar, Ali C-1517-2017 AAI-6632-2021 8342098300 55881548500 6603942124 6603131517 |
Anahtar kelimeler: | Capecitabine Cardiotoxicity Myocardial infarction Cardiovascular system & cardiology |
Yayın Tarihi: | Ağu-2009 |
Yayıncı: | Bohn Stafleu van Loghum |
Atıf: | Şentürk, T. vd. (2009). "Capecitabine-induced cardiotoxicity mimicking myocardial infarction". Netherlands Heart Journal, 17(7-8), 277-280. |
Özet: | Capecitabine, a fluoropyrimidine derivative, is an orally administered drug that delivers 5-fluorouracil (5-FU) selectively to the tumour. The drug has demonstrated activity in metastatic colorectal cancer. We describe a male patient receiving capecitabine therapy with typical chest pain and electrocardiographic changes consistent with ST-segment elevation myocardial infarction. Capecitabine-induced cardiotoxicity may develop in patients who have had a previous episode of 5-FU-induced cardiotoxicity. Capecitabine-induced cardiotoxicity is a rare condition that may lead to diagnostic and therapeutic dilemmas. |
URI: | https://doi.org/10.1007/BF03086265 https://link.springer.com/article/10.1007%2FBF03086265 http://hdl.handle.net/11452/23117 |
ISSN: | 1568-5888 |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Dosya | Açıklama | Boyut | Biçim | |
---|---|---|---|---|
Şentürk_vd_2009.pdf | 330.93 kB | Adobe PDF | Göster/Aç |
Bu öğe kapsamında lisanslı Creative Commons License